medigraphic.com
Centro Universitario de Ciencias de la Salud de la Universidad de Guadalajara y del OPD Hospitales Civiles de Guadalajara

2005, Número s1

<< Anterior Siguiente >>

Inv Salud 2005; 7 (s1)


Genómica y proteómica del virus de la Hepatitis B

Sánchez OLV, Panduro CA

Idioma: Español
Referencias bibliográficas: 34
Paginas: 12-18
Archivo PDF: 461.99 Kb.


RESUMEN

El conocimiento del genoma y proteoma del VHB ha contribuido considerablemente al desarrollo de mejores métodos diagnósticos serológicos y moleculares, de una vacuna recombinante y de tratamientos antivirales. Actualmente, se están desarrollando ensayos clínicos con el objeto de conocer más acerca de el papel que juega la variabilidad genética del virus y los factores ambientales y genéticos del hospedero en la evolución natural de la infección por el VHB; así también para conocer como esos factores influyen en el tratamiento de esta infección. En estos tiempos es muy importante entender las bases moleculares de la infección por el VHB, del diagnóstico y del tratamiento con el objeto de aplicarlo adecuadamente en la clínica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bendinelli M, Pistello M, Maggi F, Vatteroni M. Blood-Borne Hepatitis Viruses: Hepatitis B, C, D, and G viruses and TTV virus. En: Clinical Virology Manual. Editors: Specter S, Hodinka R, and Young S. 3a ed. 2000, ASM PRESS. Capitulo 27: 306-337.

  2. Feld J, Lee J, Locarnini S. New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology, 2003;38(3):545-53.

  3. Locarnini S, McMillan J, Bartholomeusz A. The hepatitis B virus and common mutants. Sem liv dis, 2003;23(1):5-20.

  4. Tiollais P, Pourcel Ch, Dejean A. The Hepatitis B virus. Nature, 1985;317:489-495.

  5. Yoffe B, Burns DK, Bhatt H, Combes B. Extraepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology, 1990;12:187-192.

  6. Strick HJ, Thornton JM, Howard CR. A topological model for Hepatitis B surface antigen. Intervirology, 1992;33:148-158.

  7. Cooreman MP, Van-Roosmalen MH, Te-Morsche R, Sunnen CMG, Sshoondermark-van de Ven EME, Jansen J, Tytgat GNJ, P.M. de Witt, and V.P. Paulij. Characterization of the reactivity pattern of murine monoclonal antibodies against wild type Hepatitis B surface antigen to G145R and other naturally occurring “a” loop escape mutantions. Hepatology, 1999;30:1287-92.

  8. Hong-Yuan H, Mei-Hwei Ch, Yen-Hsuan N, Ho-Hsiung L, Shih-Ming W, Ding-Shinn Ch. Surface gene mutants of Hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology, 1997;26:786-91.

  9. Howard CR, Allison LM. Hepatitis B surface antigen variation and protective immunity. Intervirology, 1995;38:35-40.

  10. Poovorawan Y, Theamoonlers A, Chongsriasawat V, Sanpavat S. Molecular analysis of the a determinant of HBsAg in children of HbeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect Dis, 1998;2(4):216-21.

  11. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R. The prevalence of surface antigen variants of Hepatitis B virus in Papua New Guinea, South Africa and Sardinia. Hepatology, 1997;26:1658-66.

  12. Jongerius JM, Wester M, Cuypers HTM, van Ostendorp WR, Lelie PN, van der Poel CL, van Leeuwern EF. New hepatitis B virus mutant form in a blood donor thas is undectable in several hepatitis B surface antigen screening assays. Transfusion, 1998;38:56-59.

  13. Pontisso P, Petit MA, Bankowski MJ, Peeples ME. Human liver plasma membranes contain receptors for the hepatitis B virus Pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J Virol, 1989;63(5):1981-88.

  14. Treichel U, Hermann K, Büschenfelde M, Stockert R, Poralla T, Gerken G. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J gen virol, 1994;75:3021-3029.

  15. Crowther RA, Kiselev NA, Böttcher B, Berriman JA, Borisova GP, Ose V, Pumpens P. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell, 1994;77:943-50.

  16. Heise T, Guidotti LG, Cavanaugh VJ, Chisari FV. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol, 1999;73(1):474-81.

  17. Chisari FV. Viruses, immunity and cancer: Lessons from hepatitis B. Am J Pathol, 2000;156(4):1118-32.

  18. Milich D, Jones J, Hughes J, Price J, Raney A, McLanchlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero). Proc Natl Acad Sci, 1990;87:6599-603.

  19. Koike K, Takada S. Biochemistry and functions of hepatitis B virus X protein. Intervirology, 1995;38:89-99.

  20. Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J virol, 1995;69:1851-59.

  21. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol, 1999;73(9):7231-40.

  22. Bréchot C, Degos F, Lugassy C. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med, 1985;312:270-76.

  23. Zeldis JB, Lee JH, Mamish D. Direct method for detecting small quantities of hepatitis B virus DNA in serum and plasma using the polymerase chain reaction. J Clin Invest, 1989;84:1503-508.

  24. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med, 1999;34(1):22-26.

  25. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok ASF, The US HBV epidemiology study group. Prevalence of HBV precore/core promoter variants in the United States. Hepatology, 2003;38:619-28.

  26. Parekh Sameer, Zoulim F, Ahn SH, Tsai A, Li J, Shigenobu K, Khan N, Trépo C, Wands J, Tong S. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J virol, 2003;77(12)6601-12.

  27. Norder H, Couroucé AM, Magnius LO. Complete genomes, phylogenetic relatedness and structural proteins of six strains of the Hepatitis B Virus, four of which represent two new genotypes. Virology, 1994;198:489-503.

  28. Arauz-Ruíz P, Norder H. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol, 2002;83:2059-2073.

  29. Sánchez LV, Maldonado M, Bastidas-Ramírez BE, Norder H and A. Panduro. Genotypes and S-gene variability of hepatitis B virus Mexican strains. J med virol, 2002 Sep;68:24-32.

  30. Jia-Horng K, Pei-Jer Ch, Ming-Yang L, Ding-Shinn Ch. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology, 2000;118:554-59.

  31. Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol, 2002;40(4):1207-209.

  32. Chan HL, Wong ML, Yui Hui A, Hung LC, Ka-Leung Chan F, Jao-Yiu Sung F. Hepatitis B Virus Genotype C Takes a More Aggressive Disease Course Than Hepatitis B Virus Genotype B in Hepatitis B Antigen - Positive Patients. J Clin Microbiol, 2003;41(3):1277-279.

  33. Alfonzo JC, Costa J, Sánchez-Tapias JM, Mas A, de Anta MT, Jiménez T, Rodés J. Relationship between hepatitis B virus (HBV) genotypes and HBe seroconvertion in chronic carriers and its impact on the course of infection. J Hepatol, 1999;30(Suppl 1):122.

  34. Mbayed VA, López JL, Telenta FS, Palacios G, Badía I, Fierro A, Galoppo C et al. Distribution of Hepatitis B virus genotypes in two different pediatric populations from Argentina. J Clin Microbiol, 1998;36(11):3362-65.




2020     |     www.medigraphic.com